Literature DB >> 27206762

Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.

P Fatuzzo1, G Portale1, V Scollo1, L Zanoli1, Antonio Granata2.   

Abstract

Hypomagnesemia is a common but often overlooked problem in hospitalized patients. Unrecognized hypomagnesemia can cause serious complications. The association of hypokalemia and hypocalcemia is strongly evocative of a magnesium deficiency. Research into the causes of hypomagnesemia is imperative, as it will definitely change the approach, treatment and prognosis. We report the case of a 65-year-old man with chronic hypocalcemia and hypokalemia associated with cerebellar syndrome, a solitary seizure and cerebellar hyperintensities on magnetic resonance imaging. After the detection and treatment of hypomagnesemia with oral supplements of magnesium and the replacement of pantoprazole with ranitidine, we observed immediate relief of the symptoms. In conclusion, in clinical practice, magnesium depletion should be investigated in elderly patients with hypocalcemia treated with proton pump inhibitors for many years, in particular in the presence of neurological disorders.

Entities:  

Keywords:  Hypocalcemia; Hypokalemia; Hypomagnesemia; Hypoparathyroidism; Proton pump inhibitors

Mesh:

Substances:

Year:  2016        PMID: 27206762     DOI: 10.1007/s40620-016-0319-0

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  14 in total

1.  Magnesium modulates ROMK channel-mediated potassium secretion.

Authors:  Lei Yang; Gustavo Frindt; Lawrence G Palmer
Journal:  J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 10.121

2.  [Magnesium, calcium and potassium: "no one was born alone"].

Authors:  Francesco Rapisarda; Grazia Portale; Silvia Ferrario; Concetto Sessa; Roberta Aliotta; Luca Zanoli; Pasquale Fatuzzo
Journal:  G Ital Nefrol       Date:  2016 Jan-Feb

3.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

4.  Secretion and metabolic efficacy of parthyroid hormone in patients with severe hypomagnesemia.

Authors:  L R Chase; E Slatopolsky
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

5.  Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone.

Authors:  Masahiro Yamamoto; Toru Yamaguchi; Mika Yamauchi; Shozo Yano; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2011-05-19       Impact factor: 2.626

Review 6.  Magnesium in man: implications for health and disease.

Authors:  Jeroen H F de Baaij; Joost G J Hoenderop; René J M Bindels
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

7.  Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone.

Authors:  J J Freitag; K J Martin; M B Conrades; E Bellorin-Font; S Teitelbaum; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

8.  Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia.

Authors:  Tom Nijenhuis; Joost G J Hoenderop; René J M Bindels
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

9.  A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients.

Authors:  E T Wong; R K Rude; F R Singer; S T Shaw
Journal:  Am J Clin Pathol       Date:  1983-03       Impact factor: 2.493

10.  Treatment of hypomagnesemia.

Authors:  John Ayuk; Neil J L Gittoes
Journal:  Am J Kidney Dis       Date:  2013-10-04       Impact factor: 8.860

View more
  4 in total

1.  Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors.

Authors:  Fernanda A Goncalves; Jessica Santos de Jesus; Lilian Cordeiro; Maria Clara T Piraciaba; Luiza K R P de Araujo; Carolina Steller Wagner Martins; Maria Aparecida Dalboni; Benedito J Pereira; Bruno C Silva; Rosa Maria A Moysés; Hugo Abensur; Rosilene M Elias
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

2.  Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety Signals.

Authors:  Florence van Hunsel; Laura Peters; Helga Gardarsdottir; Agnes Kant
Journal:  Drug Saf       Date:  2021-02-19       Impact factor: 5.606

3.  Letter regarding the article "The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study".

Authors:  Pasquale Fatuzzo; Luca Zanoli; Viviana Scollo
Journal:  Clin Interv Aging       Date:  2017-04-28       Impact factor: 4.458

4.  Posterior Reversible Encephalopathy Syndrome due to Hypomagnesemia: A Case Report and Literature Review.

Authors:  Mohamad Almoussa; Angelika Goertzen; Stephan Brauckmann; Barbara Fauser; Christoph W Zimmermann
Journal:  Case Rep Med       Date:  2018-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.